To Study the EGG Abnormalities in Healthy Subjects and in Patients With Idiopathic and Diabetic Gastroparesis.

NCT ID: NCT05624034

Last Updated: 2022-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Electrogastrogram (EGG) is a non-invasive method for recording myoelectric activities by placing electrodes on the abdomen surface. Many studies suggested EGG measures the gastric slow wave frequency effectively; the relative change in EGG signal amplitude would reflect the contractility of the stomach. Thus, this technique is used to study the pathophysiological processes of diseases such as functional dyspepsia and many more .

The present study aims to study the EGG pattern in healthy individuals in Indian population and the factors associated with it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Electrogastrogram \[EGG\] is an authentic method to detect gastrointestinal diseases accompanied by gastric motility abnormalities . The present study would help to determine the normatic values of EGG in healthy population and EGG changes in patients with idiopathic gastroparesis. This pilot study would provide findings/abnormalities seen in study population and may be helpful in providing a comparative data for proper treatment and a better quality of life patients suffering from dyspepsia.

All the eligible subjects will undergo study procedure i.e. EGG. The study procedure will conduct as per standard study protocol. EGG is a non-invasive, painless method for the measurement of gastric myoelectrical activity. EGG takes around two hours to complete the procedure and no side effects reported. Following steps are included in the procedure

* Subject lie on back on a procedure table.
* Investigator or technician tapes electrodes to Subject's abdomen (belly). The electrodes are similar to those used for other tests, such as an ECG (electrocardiogram). The electrodes measure electrical signals coming from stomach muscles. They send the signals to a computer that records the signals as a graph.
* Investigator or technician records a test while Subject's stomach is empty. An hour later, Subject have something to eat and drink. Investigator or technician then records a second test. The test and electrodes are painless.
* The electrodes are removed. EGG test is completed at this point.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroparesis Diabetes Complications Idiopathic Gastric Motility Disorder Dyspepsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy group

Subjects with no previous medical history (healthy volunteers) will be assessed for eligibility criteria.

Electrogastrography

Intervention Type DEVICE

Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis

Idiopathic Gastroparesis

Patients with symptoms of Gastroparesis based on ROME IV criteria and not having a known cause of gastroparesis like endocrine, neurological, rheumatological disorder.

Electrogastrography

Intervention Type DEVICE

Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis

Diabetic Gastroparesis

Patients with symptoms of Gastroparesis based on ROME IV criteria and Diabetes mellitus of any duration.

Electrogastrography

Intervention Type DEVICE

Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrogastrography

Electrogastrography is used to study abnormalities in healthy subjects and in patients with Diabetic and Idiopathic Gastroparesis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must meet the following criteria to be included in the study:
* Healthy subjects 20 Males and 20 females subjects atleast one will be taken from each group \[18-20,20-30,30-40,40-50,50-60,60-70yrsAbsence of previous upper gastrointestinal surgery anytime in past.
* Absence of drugs which affect the upper gastrointestinal system in 3 months.
* Absence of diabetes,thyroid disorder or neuromuscular disorder.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Idiopathic Gastroparesis
* Male and female subjects above 18 to 70 years of age.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Patient's having symptoms of dyspepsia based on ROME IV Criteria and not having a known cause of gastroparesis like endocrine, neurological, rheumatological disorder.
* ROME IV criteria for Functional Dyspepsia\* (Diagnostic criteria\*\*): One or more of the following
* Bothersome postprandial fullness
* Bothersome early satiation
* Bothersome epigastric pain
* Bothersome epigastric burning AND
* No evidence of structural disease (including at upper endoscopy) that is likely to explain the symptoms

-\*Must fulfill criteria for Postprandial Distress Syndrome (PDS) and/or Epigastric Pain Syndrome (EPS)

-\*\*Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis
* Diabetic Gastroparesis
* Male and female subjects above 18 to 70 years of age.
* Subject who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure
* Subject willing to use appropriate method of contraception as per investigator's discretion, throughout the study
* Patient's having symptoms of dyspepsia based on ROME IV Criteria and Diabetes mellitus of any duration

Exclusion Criteria

* Subjects who meet any of the following criteria will be excluded from the study:
* For Idiopathic Gastroparesis
* Subjects suffering from Diabetes
* Subjects with history of any bariatric procedures/ gastric surgeries in the past
* Females who are pregnant
* Subjects taking following medications within 72 hours to the start of the study: Opioids, TCA, Calcium channel blockers, anti-psychotics, anti-cholinergic, steroids, L-Dopa
* Subjects with electrolyte abnormalities like hypokalaemia, hypomagnesemia
* Subjects with known cases of thyroid disorder (hypo or hyperthyroidism)
* Subjects who are unsuitable for any other reason to participate in the study in the opinion of the investigator
* For Diabetic Gastroparesis
* Subjects with history of any bariatric procedures/ gastric surgeries in the past
* Females who are pregnant
* Subjects taking following medications within 72 hours to the start of the study: Opioids, TCA, Calcium channel blockers, anti-psychotics, anti-cholinergic, steroids, L-Dopa
* Subjects with electrolyte abnormalities like hypokalaemia, hypomagnesemia
* Subjects with known cases of thyroid disorder (hypo or hyperthyroidism)
* Subjects who are unsuitable for any other reason to participate in the study in the opinion of the investigator.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asian Institute of Gastroenterology, India

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rakesh Kalapala

Director Endoscopy[ Center for obesity and metabolic therapy]

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rakesh Kalapala, MBBS,MD,DM

Role: STUDY_DIRECTOR

Senior consultant

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AIG Hospitals

Hyderabad, Telangana, India

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Neeraj Singla, MBBS,MD,DM

Role: CONTACT

7013454913

References

Explore related publications, articles, or registry entries linked to this study.

Riezzo G, Russo F, Indrio F. Electrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activity. Biomed Res Int. 2013;2013:282757. doi: 10.1155/2013/282757. Epub 2013 May 25.

Reference Type BACKGROUND
PMID: 23762836 (View on PubMed)

Al Kafee A, Akan A. Analysis of gastric myoelectrical activity from the electrogastrogram signals based on wavelet transform and line length feature. Proc Inst Mech Eng H. 2018 Apr;232(4):403-411. doi: 10.1177/0954411918757812. Epub 2018 Feb 14.

Reference Type BACKGROUND
PMID: 29441814 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AIG/IEC-BH&R32/07.2022-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gastroparesis Registry 3
NCT03680859 COMPLETED
Nutritional Drink in Gastroparesis
NCT03500354 WITHDRAWN NA
Gastroparesis Registry 4
NCT05846802 RECRUITING
The Use of Domperidone for Gastroparesis
NCT01378884 WITHDRAWN PHASE3